1. Home
  2. FGEN vs AERT Comparison

FGEN vs AERT Comparison

Compare FGEN & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • AERT
  • Stock Information
  • Founded
  • FGEN 1993
  • AERT 2012
  • Country
  • FGEN United States
  • AERT Singapore
  • Employees
  • FGEN N/A
  • AERT N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • AERT Professional Services
  • Sector
  • FGEN Health Care
  • AERT Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • AERT Nasdaq
  • Market Cap
  • FGEN 34.5M
  • AERT 33.5M
  • IPO Year
  • FGEN 2014
  • AERT N/A
  • Fundamental
  • Price
  • FGEN $0.50
  • AERT $0.61
  • Analyst Decision
  • FGEN
  • AERT
  • Analyst Count
  • FGEN 0
  • AERT 0
  • Target Price
  • FGEN N/A
  • AERT N/A
  • AVG Volume (30 Days)
  • FGEN 885.8K
  • AERT 70.8K
  • Earning Date
  • FGEN 02-24-2025
  • AERT 02-19-2025
  • Dividend Yield
  • FGEN N/A
  • AERT N/A
  • EPS Growth
  • FGEN N/A
  • AERT N/A
  • EPS
  • FGEN N/A
  • AERT N/A
  • Revenue
  • FGEN $180,015,000.00
  • AERT $72,141,000.00
  • Revenue This Year
  • FGEN $21.91
  • AERT N/A
  • Revenue Next Year
  • FGEN N/A
  • AERT N/A
  • P/E Ratio
  • FGEN N/A
  • AERT N/A
  • Revenue Growth
  • FGEN 16.15
  • AERT 16.98
  • 52 Week Low
  • FGEN $0.18
  • AERT $0.51
  • 52 Week High
  • FGEN $2.93
  • AERT $2.93
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 49.50
  • AERT 34.83
  • Support Level
  • FGEN $0.46
  • AERT $0.53
  • Resistance Level
  • FGEN $0.51
  • AERT $0.65
  • Average True Range (ATR)
  • FGEN 0.05
  • AERT 0.11
  • MACD
  • FGEN -0.01
  • AERT -0.02
  • Stochastic Oscillator
  • FGEN 31.25
  • AERT 13.90

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

Share on Social Networks: